Brief by Shorts91 Newsdesk / 04:38am on 07 Apr 2024,Sunday India Global
UK researchers, including Dr. Ashvini Keshavan of UCL, have clinched a significant grant to advance dementia blood tests. They zero in on p-tau217, a promising Alzheimer's biomarker, while a parallel team from Oxford and Cambridge explores proteins for diverse dementia types. Recruiting nationwide, they aim for NHS integration within five years. Dr. Keshavan underscores the blood's potential in diagnosing Alzheimer's and other dementias.
